mk-0524 and Kidney-Failure--Chronic

mk-0524 has been researched along with Kidney-Failure--Chronic* in 1 studies

Other Studies

1 other study(ies) available for mk-0524 and Kidney-Failure--Chronic

ArticleYear
Sustained hypophosphatemic effect of once-daily niacin/laropiprant in dyslipidemic CKD stage 3 patients.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2011, Volume: 57, Issue:6

    Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyslipidemias; Humans; Hypolipidemic Agents; Hypophosphatemia; Indoles; Kidney Failure, Chronic; Lipids; Niacin; Treatment Outcome

2011